Should metformin be continued after hospital admission in patients with COVID-19?- RETRACTED

Nasser Mikhail, Soma Wali

Abstract


Retraction note:

Based on COPE guidelines the article was retracted by Editor-in-Chief:

The findings have previously been published elsewhere without proper attribution to previous sources or disclosure to the editor, permission to republish, or justification (ie, cases of redundant publication).


Redundant publication:

Diabetes Research: Open Access
DOI: 10.36502/2020/droa.6171
Diab Res Open Access. 2020 Oct 10;2(3):68-71

Available at: 

https://asploro.com/safety-of-metformin-in-hospitalized-patients-with-covid-19/

 

 


Keywords


COVID-19, Diabetes, Metformin, Safety, Mortality, Lactic acidosis

Full Text:

Full-text PDF

References


Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020; 14(4):303-10.

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020; 382(18):1708-20.

Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020; 14(4):395-403.

American Diabetes Association. Pharmacologic approaches to glycemic treatment. Standards of Medical Care in diabetes-2020; 43: S98-S110.

American Diabetes Association. Diabetes care in the hospital: Standards of Medical Care in diabetes-2020; 43: S193-S201.

Kow CS, Hasan SS. Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis. J Med Virol. 2020. [In press]. doi: 10.1002/jmv.26498.

Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, et al. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19. medRxiv. 2020. [Preprint]. doi: 10.1101/2020.06.19.20135095.

Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin Use is Associated with Reduced Mortality in a Diverse Population with Covid-19 and Diabetes. medRxiv. 2020. [Preprint]. doi: 10.1101/2020.07.29.20164020.

Cheng X, Liu Y-M, Li H, Zhang X, Lei F, Qin J-J, et al. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metabolism. 2020. [In press]. doi: 10.1016/j.cmet.2020.08.013

DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016; 65(2):20-9.

Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circ Res. 2016; 119(5):652-65.

Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020; 43(7):1399-407.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.